US76155X1000
US76155X1000
Revolution Medicines, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 1.182.369.000 | 689.524.000 | 71.5% | |
| Operating Income | -1.182.369.000 | -689.524.000 | 71.5% |
| Pretax Income | -1.131.301.000 | -600.846.000 | 88.3% |
| Net Income Common Stockholders | -1.131.301.000 | -600.093.000 | 88.5% |
| -- | -- | -- | |
| -- | -- | -- |